Table 1.
Clinical Trials with Vorinostat As Single Drug
| NCT number | Study results | Conditions | Phases | Funded by | Start data |
|---|---|---|---|---|---|
| NCT00305773 | Has results | AML (different Fab classifications) | 2 | NIH | January 2006 |
| NCT00128102 | No results available | Mesothelioma|Lung cancer | 3 | Industry | June 2005 |
| NCT00278330 | No results available | BLCML|Recurrent ALL|Recurrent ALL|RAEB|Relapsing CML|ALL|AML | 1 | NIH | January 2006 |
| NCT00132067 | No results available | Primary peritoneal cavity cancer|Recurrent ovarian epithelial cancer | 2 | NIH | October 2005 |
| NCT00330161 | No results available | Recurrent prostate cancer|Stage IV prostate cancer | 2 | NIH | March 2006 |
| NCT00363883 | No results available | Localized, metastatic, recurrent, regional TCC of the renal pelvis and ureter|TCC of the bladder | 2 | NIH | June 2006 |
| NCT00641706 | No results available | Adult giant cell glioblastoma|Adult glioblastoma|Adult gliosarcoma|Brain tumor | 2 | NIH | July 2008 |
| NCT00238303 | No results available | Adult giant cell glioblastoma|Adult glioblastoma|Adult gliosarcoma|Brain tumor | 2 | NIH | September 2005 |
| NCT00132002 | No results available | Male breast cancer|Recurrent breast cancer|Stage IV breast cancer | 2 | NIH | June 2005 |
| NCT00776503 | No results available | Myelodysplastic syndromes | 1/2 | Other|Industry | May 2008 |
| NCT00134043 | No results available | Thyroid cancer | 2 | NIH | December 2005 |
| NCT00479232 | Has results | Leukemia, myelocytic, acute MDS|MDS | 1 | Industry | June 2007 |
| NCT00632931 | Has results | Advanced cancer relapsed|Advanced cancer refractory | 1 | Industry | June 2007 |
| NCT00907738 | Has results | Advanced cancer | 2 | Industry | August 2005 |
| NCT00132028 | Has results | Lymphoma | 2 | NIH | September 2005 |
| NCT00771472 | Has results | Lymphoma | 1 | Industry | August 2008 |
| NCT00336141 | No results available | Colorectal cancer | 1 | Other|Industry | June 2006 |
| NCT00373490 | Has results | Tumors | 1 | Industry | July 2006 |
| NCT00127127 | No results available | Tumors | 1 | Industry | June 2005 |
| NCT00138203 | No results available | Lung cancer | 2 | Other|NIH | January 2006 |
| NCT00045006 | No results available | Cancer | 1 | Other|NIH | July 2001 |
| NCT00455351 | No results available | Pelvic cancer | 1 | Other | February 2007 |
| NCT00005634 | No results available | Leukemia|Lymphoma|MM and PCN|Prostate cancer|Small intestine cancer | 1 | Other|NIH | January 2000 |
| NCT00127140 | No results available | Lymphoma | 1 | Industry | June 2005 |
| NCT00097929 | No results available | B-cell lymphoma | 2 | Industry | May 2005 |
| NCT00091559 | No results available | Cutaneous T-cell lymphoma|Sezary syndrome|Mycosis fungoides | 2 | Industry | February 2005 |
| NCT00750178 | No results available | Cancer, Advanced | 1 | Industry | November 2004 |
| NCT00858234 | No results available | Multiple myeloma | 1 | Industry | March 2009 |
ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; BLCML, blastic phase of chronic myeloid leukemia; CML, chronic myeloid leukemia; MDS, myelodysplastic syndrome; MM, multiple myeloma; PCN, plasma cell neoplasm; RAEB, refractory anemia with excess blasts; TCC, transitional cell carcinoma.